Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease
about
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionAdditional mechanisms conferring genetic susceptibility to Alzheimer's diseaseGenetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkersRole of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesisGWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNIThe PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriersRoles of tau protein in health and disease.Alzheimer's disease risk genes and the age-at-onset phenotype.Genetic modification of the relationship between phosphorylated tau and neurodegeneration.Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathologyGenome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammationAlzheimer's disease risk genes and mechanisms of disease pathogenesisesyN: network building, sharing and publishingExpression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains.Epistatic genetic effects among Alzheimer's candidate genes.Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's diseaseEffect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotypeAlzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding.Recent Developments in Understanding Brain Aging: Implications for Alzheimer's Disease and Vascular Cognitive Impairment.Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohortsCLU genetic variants and cognitive decline among elderly and oldest oldMissense variant in TREML2 protects against Alzheimer's disease.Genetic discoveries in AD using CSF amyloid and tau.Etiology and pathogenesis of late-onset Alzheimer's disease.Alzheimer's disease genetics: from the bench to the clinic.The Role of PICALM in Alzheimer's Disease.State of Play in Alzheimer's Disease Genetics.Genetic Variants and Related Biomarkers in Sporadic Alzheimer's Disease.Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits.Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.7B2 chaperone knockout in APP model mice results in reduced plaque burden.Genetics of Alzheimer's disease
P2860
Q27006831-4D9944F6-DB56-4731-BF47-9C12E9860607Q28391511-1B78AA16-8C74-4E66-A4F5-675F9BD5CD4BQ28542010-34C7B19D-1BBB-4BB8-8AE3-9A5E1FD5D1F3Q28587217-49420AB2-CFBB-48F2-8441-951419182857Q29417137-D701492C-56DA-4BE0-8BC2-5046CB5CB5A9Q30845482-7190B175-54A8-49B3-8E95-0793B947D590Q30971403-8D5CA01E-0DBB-46FF-B37D-15657D88C3B7Q31110973-44802BFA-EFBF-4C7B-9C2D-C2A22558DA2AQ31129910-882D9549-4C95-4C6E-9438-3379760EE49BQ33559303-6E299792-2750-491B-BFF6-22A763ACC301Q33685232-27CB86A9-E2C9-423A-93EE-15C839D9EEE2Q34216985-A96B6E7A-3138-4914-8743-55FD191A6CD1Q34345159-0D78D6D7-C9C7-4421-94F8-328BAE1CD5E7Q34394932-CA3402C5-2F90-4CA2-9283-8FF2A04AAE87Q34425904-0A3EEB16-BD69-4410-AF1A-5F2E633B317AQ34436467-48206E54-C6A7-41DC-BCCF-9CFCD4E657DFQ34506196-429D00F5-7495-4F3D-9278-2B3CB117A738Q35049287-C6DB1DC2-3E52-4598-9189-E7E765EF3847Q36283394-890971A2-A716-42E5-9E16-597DCDB24C42Q36503998-EDBDFA1E-C48A-442E-B562-B22018F860DEQ36733874-4CE25771-D932-4095-9D72-6CE47838FC29Q36853502-EAB167AB-0C73-4439-A6E9-0C323ADEF500Q36941597-CB6F5F81-3AAB-4E01-8187-363E0B5BF45AQ37309231-E57A126A-F61C-416E-B7C8-162B1468FB1FQ37653009-841DCAF4-40A0-4683-8CDB-6AD39443E9A3Q37692079-91F80E7E-E64D-48CB-8DED-3AA59352A072Q38178837-7926ACAB-96AE-4D1A-AB35-CC1C20500949Q38225911-FD043245-4EB7-40A2-9618-4804ECDEE2B5Q38245888-303B9B26-144B-4F47-BBBA-72CAD2D8148CQ39307376-35ACC538-D2A9-4582-A336-34E2AA9665BDQ43132552-8D7C7EE7-A994-46BA-8D35-16D0C98CD0F6Q46000774-A0E509E3-C1BF-4071-B5E0-6C5651CD3809Q48818980-8892834F-C78B-4C1A-9CAC-78494288500AQ55514800-9F097DE0-A3FF-4AE4-89EE-D925A1FC6C9AQ58920538-4AA08136-FE0C-4C87-B2ED-151A84601185
P2860
Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Fine mapping of genetic varian ...... arkers for Alzheimer's disease
@ast
Fine mapping of genetic varian ...... arkers for Alzheimer's disease
@en
type
label
Fine mapping of genetic varian ...... arkers for Alzheimer's disease
@ast
Fine mapping of genetic varian ...... arkers for Alzheimer's disease
@en
prefLabel
Fine mapping of genetic varian ...... arkers for Alzheimer's disease
@ast
Fine mapping of genetic varian ...... arkers for Alzheimer's disease
@en
P2093
P2860
P50
P921
P1433
P1476
Fine mapping of genetic varian ...... arkers for Alzheimer's disease
@en
P2093
Brooke Sadler
John S K Kauwe
Kevin Mayo
Manti Su'a
Wayne Latu
P2860
P304
P356
10.1371/JOURNAL.PONE.0015918
P407
P50
P577
2011-02-09T00:00:00Z